leisure time -WSS

leisure time

author：explore 2025-09-06 09:18:47 - browse：93753

When is a billion-dollar deal a bad omen? Has Wall Street gone overboard on Ozempic? And how do you edit a chicken?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss Bristol Myers Squibb’s multibillion-dollar acquisition of Mirati Therapeutics and what it means for a biotech sector still in a slump. We also explain the latest news in the life sciences, including Wall Street’s freakout over GLP-1, CRISPR’ing animals, and the latest in the NASH saga.

For more on what we cover, here’s the news on Mirati; here’s more on biotech venture capital; here’s the latest on Alnylam Pharmaceuticals; here’s more on NASH; here’s the story on xenotransplantation; here’s more on genome-edited chickens; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Ohio train derailment: Experts on toxic chemical risks

Wikipedia

explore

WSS

CDC director unscathed in first congressional testimony

UnitedHealth’s Optum accused of antitrust violations in California

Will the market for weight loss drugs really reach $100 billion?

BIO selects John Crowley as new CEO

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Using force crossed my mind when examining a defiant young patient

explore

leisure time

focus

Medicare details structure of new drug price negotiation program

5 ways to address the shortage of health care workers

Walensky prepares to leave CDC — and Congress — behind

Doctor of U.S. President Joe Biden says he is fit for duty

How to save PrEP access — and even expand it

Despite FDA concern, risk that CAR

Peter Hotez and the public health issue of online harassment

30 years of 'Listening to Prozac'

Cancer drug shortages should be causing more outrage

Ohio train derailment: Experts on toxic chemical risks

entertainment

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Organ aging and disease risk measured by new blood test

Flagship Pioneering launches a new biotech in two countries

What to do when lifesaving products contribute to climate change

Virtual repurposing can help discover new uses for existing drugs

focus

Wikipedia

explore

hotspot